Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation

Molecular Biology of the Cell

Volumn 19, Issue 11, 2008, Pages 4814-4825

  Rocha, Ana Sofia ^a,b   Paternot, Sabine ^a   Coulonval, Katia ^a   Dumont, Jacques E ^a   Soares, Paula ^b   Roger, Pierre P ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIC AMP; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN RET; RAF PROTEIN; B RAF KINASE; BRAF PROTEIN, HUMAN; CDK4 PROTEIN, HUMAN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN A; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE ACTIVATING KINASE; CYCLIN-DEPENDENT KINASE-ACTIVATING KINASE; CYCLINE; DNA; FORSKOLIN; PROTEIN KINASE; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THYMOCYTE; THYROID CARCINOMA; BIOSYNTHESIS; CELL CYCLE; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PHOSPHORYLATION; THYROID TUMOR; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIN A; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA, NEOPLASM; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FORSKOLIN; HUMANS; MUTATION; PHOSPHORYLATION; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS B-RAF; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; THYROID NEOPLASMS;

EID: 58149306363     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-06-0617     Document Type: Article

References (89)

1. Alt, J. R., Gladden, A. B., Diehl, J. A. (2002). p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J. Biol. Chem. 277, 8517-8523.
2. Balmanno, K., Millar, T., McMahon, M., Cook, S. J. (2003). DeltaRaf-1, ER* bypasses the cyclic AMP block of extracellular signal-regulated kinase 1 and 2 activation but not CDK2 activation or cell cycle reentry. Mol. Cell. Biol. 23, 9303-9317.
3. Blain, S. W., Montalvo, E., Massague, J. (1997). Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem. 272, 25863-25872.
4. Bockstaele, L., Coulonval, K., Kooken, H., Paternot, S., and Roger, P. P. (2006a). Regulation of CDK4. Cell Div. 1, 25.
5. Bockstaele, L., Kooken, H., Libert, F., Paternot, S., Dumont, J. E., de Launoit, Y., Roger, P. P., and Coulonval, K. (2006b). Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors." Mol. Cell. Biol. 26, 5070-5085.
6. Bos, J. L. (2006). Epac proteins: multi-purpose cAMP targets. Trends Biochem. Sci. 31, 680-686.
7. Boynton, A. L., and Whitfield, J. F. (1983). The role of cyclic AMP in cell proliferation: A critical assessment of the evidence. Adv. Cyclic. Nucleotide. Res. 15, 193-294.
8. Calebiro, D., de Filippis, T., Lucchi, S., Martinez, F., Porazzi, P., Trivellato, R., Locati, M., Beck-Peccoz, P., and Persani, L. (2006). Selective modulation of protein kinase A I and II reveals distinct roles in thyroid cell gene expression and growth. Mol. Endocrinol. 20, 3196-3211.
9. Calipel, A., Mouriaux, F., Glotin, A. L., Malecaze, F., Faussat, A. M., and Mascarelli, F. (2006). Extracellular signal-regulated kinase-dependent proliferation is mediated through the protein kinase A/B-Raf pathway in human uveal melanoma cells. J. Biol. Chem. 281, 9238-9250.
10. Christensen, A. E., Selheim, F., de Rooij, J., Dremier, S., Schwede, F., Dao, K. K., Martinez, A., Maenhaut, C., Bos, J. L., Genieser, H. G., and Doskeland, S. O. (2003). cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J. Biol. Chem. 278, 35394-35402.
11. Cocks, B. G., Vairo, G., Bodrug, S. E., and Hamilton, J. A. (1992). Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. J. Biol. Chem. 267, 12307-12310.
12. Cook, S. J., and McCormick, F. (1993). Inhibition by cAMP of Ras-dependent activation of Raf. Science 262, 1069-1072.
13. Coulonval, K., Bockstaele, L., Paternot, S., Dumont, J. E., and Roger, P. P. (2003a). The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its sub-units demonstrated by two-dimensional gel electrophoresis. Exp. Cell Res. 291, 135-149.
14. Coulonval, K., Bockstaele, L., Paternot, S., and Roger, P. P. (2003b). Phosphorylations of cyclin-dependent kinase 2 revisited using two-dimensional gel electrophoresis. J. Biol. Chem. 278, 52052-52060.
15. Cowlen, M. S., and Eling, T. E. (1992). Modulation of c-jun and jun-B messenger RNA and inhibition of DNA synthesis by prostaglandin E2 in Syrian hamster embryo cells. Cancer Res. 52, 6912-6916.
16. Depoortere, F., Dumont, J. E., and Roger, P. P. (1996). Paradoxical accumulation of the cyclin-dependent kinase inhibitor p27kip1 during the cAMP-dependent mitogenic stimulation of thyroid epithelial cells. J. Cell Sci. 109, 1759-1764.
17. Depoortere, F., Pirson, I., Bartek, J., Dumont, J. E., and Roger, P. P. (2000). Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-CDK4 with nuclear p27(kip1). Mol. Biol. Cell 11, 1061-1076.
18. Depoortere, F., Van Keymeulen, A., Lukas, J., Costagliola, S., Bartkova, J., Dumont, J. E., Bartek, J., Roger, P. P., and Dremier, S. (1998). A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. J. Cell Biol. 140, 1427-1439.
19. Dremier, S., Milenkovic, M., Blancquaert, S., Dumont, J. E., Doskeland, S. O., Maenhaut, C., and Roger, P. P. (2007). Cyclic adenosine 3′,5′-monophosphate (cAMP)-dependent protein kinases, but not exchange proteins directly activated by cAMP (Epac), mediate thyrotropin/cAMP-dependent regulation of thyroid cells. Endocrinology 148, 4612-4622.
20. Dumaz, N., Light, Y., and Marais, R. (2002). Cyclic AMP blocks cell growth through Raf-1-dependent and Raf-1-independent mechanisms. Mol. Cell. Biol. 22, 3717-3728.
21. Dumaz, N., and Marais, R. (2003). Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. J. Biol. Chem. 278, 29819-29823.
22. Dumaz, N., and Marais, R. (2005). Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. FEBS J. 272, 3491-3504.
23. Dumont, J. E., Jauniaux, J. C., and Roger, P. P. (1989). The cyclic AMP-mediated stimulation of cell proliferation. Trends. Biochem. Sci. 14, 67-71.
24. Duprez, L., Parma, J., Van Sande, J., Allgeier, A., Leclere, J., Schvartz, C., Delisle, M. J., Decoulx, M., Orgiazzi, J., and Dumont, J. (1994). Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat. Genet. 7, 396 -401.
25. Fisher, R. P. (2005). Secrets of a double agent: CDK7 in cell-cycle control and transcription. J. Cell Sci. 118, 5171-5180.
26. Friedman, D. L. (1976). Role of cyclic nucleotides in cell growth and differentiation. Physiol Rev. 56, 652-708.
27. Fuhrer, D., Tannapfel, A., Sabri, O., Lamesch, P., and Paschke, R. (2003). Two somatic TSH receptor mutations in a patient with toxic metastasising follicular thyroid carcinoma and non-functional lung metastases. Endocr. Relat. Cancer 10, 591-600.
28. Graves, L. M., Bornfeldt, K. E., Raines, E. W., Potts, B. C., Macdonald, S. G., Ross, R., and Krebs, E. G. (1993). Protein kinase A antagonizes platelet- derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl. Acad. Sci. USA 90, 10300-10304.
29. Heldin, N. E., Paulsson, Y., Forsberg, K., Heldin, C. H., and Westermark, B. (1989). Induction of cyclic AMP synthesis by forskolin is followed by a reduction in the expression of c-myc messenger RNA and inhibition of 3H-thymidine incorporation in human fibroblasts. J. Cell Physiol. 138, 17-23.
30. Kaldis, P. (1999). The cdk-activating kinase (CAK): from yeast to mammals. Cell Mol. Life Sci. 55, 284-296.
31. Kaldis, P., Russo, A. A., Chou, H. S., Pavletich, N. P., and Solomon, M. J. (1998). Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities. Mol. Biol. Cell 9, 2545-2560.
32. Kato, J. Y., Matsuoka, M., Polyak, K., Massague, J., and Sherr, C. J. (1994). Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79, 487-496.
33. Kimura, T., Van Keymeulen, A., Golstein, J., Fusco, A., Dumont, J. E., and Roger,P. P. (2001). Regulation ofthyroid cell proliferation bythyrotropin and other factors : a critical evaluation of in vitro models. Endocr. Rev. 22, 631-656.
34. Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., and Stratakis, C. A. (2000). Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat. Genet. 26, 89-92.
35. Kitagawa, M. et al. (1996). The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15, 7060-7069.
36. Kondo, T., Ezzat, S., and Asa, S. L. (2006). Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat. Rev. Cancer 6, 292-306.
37. Kuiperij, H. B., van der Horst, A., Raaijmakers, J., Weijzen, S., Medema, R. H., Bos, J. L., Burgering, B. M., Zwartkruis, F. J. (2005). Activation of FoxO transcription factors contributes to the antiproliferative effect of cAMP. Oncogene 24, 2087-2095.
38. L'Allemain, G., Lavoie, J. N., Rivard, N., Baldin, V., and Pouyssegur, J. (1997). Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene 14, 1981-1990.
39. LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., and Harlow, E. (1997). New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11, 847-862.
40. Larochelle, S., Merrick, K. A., Terret, M. E., Wohlbold, L., Barboza, N. M., Zhang, C., Shokat, K. M., Jallepalli, P. V., and Fisher, R. P. (2007). Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. Mol. Cell 25, 839 -850.
41. Laurent, E., Van Sande, J., Ludgate, M., Corvilain, B., Rocmans, P., Dumont, J. E., and Mockel, J. (1991). Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices. J. Clin. Invest. 87, 1634-1642.
42. Lavoie, J. N., L'Allemain, G., Brunet, A., Muller, R., and Pouyssegur, J. (1996). Cyclin D1 expression is regulated positively by the p42/p44MAPK and negativelybythe p38/HOGMAPK pathway. J. Biol. Chem. 271, 20608-20616.
43. Ledent, C., Dumont, J. E., Vassart, G., and Parmentier, M. (1992). Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J. 11, 537-542.
44. Lyons, J., Landis, C. A., Harsh, G., Vallar, L., Grunewald, K., Feichtinger, H., Duh, Q. Y., Clark, O. H., Kawasaki, E., and Bourne, H. R. (1990). Two G protein oncogenes in human endocrine tumors. Science 249, 655-659.
45. Ma, L., Teruya-Feldstein, J., Bonner, P., Bernardi, R., Franz, D. N., Witte, D., Cordon-Cardo, C., and Pandolfi, P. P. (2007). Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. Cancer Res. 67, 7106-7112.
46. Matsuoka, M., Kato, J. Y., Fisher, R. P., Morgan, D. O., and Sherr, C. J. (1994). Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol. 14, 7265-7275.
47. Mechta, F., Piette, J., Hirai, S. I., and Yaniv, M. (1989). Stimulation of protein kinase C or protein kinase A mediated signal transduction pathways shows three modes of response among serum inducible genes. New Biol. 1, 297-304.
48. Meireles, A. M. et al. (2007). Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines. Thyroid 17, 707-715.
49. Mircescu, H., Parma, J., Huot, C., Deal, C., Oligny, L. L., Vassart, G., and Van Vliet, G. (2000). Hyperfunctioning malignant thyroid nodule in an 11-year-old girl: pathologic and molecular studies. J. Pediatr. 137, 585-587.
50. Mitsutake, N., Miyagishi, M., Mitsutake, S., Akeno, N., Mesa, J. C., Knauf, J. A., Zhang, L., Taira, K., and Fagin, J. A. (2006). BRAF mediates RET/PTC- induced MAPK activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis. Endocrinology 147, 1014-1019.
51. Motti, M. L. et al. (2003). Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland. Oncogene 22, 7576-7586.
52. Motti, M. L. et al. (2007). Loss of p27 expression through RAS→BRAF→MAP kinase-dependent pathway in human thyroid carcinomas. Cell Cycle 6, 2817-2825.
53. Nagahara, H., Ezhevsky, S. A., Vocero-Akbani, A. M., Kaldis, P., Solomon, M. J., and Dowdy, S. F. (1999). Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity. Proc. Natl. Acad. Sci. USA 96, 14961-14966.
54. Ohta, K., Pang, X. P., Berg, L., and Hershman, J. M. (1997). Growth inhibition of new human thyroid carcinoma cell lines by activation of adenylate cyclase through the beta-adrenergic receptor. J. Clin. Endocrinol. Metab. 82, 2633-2638.
55. Parma, J., Duprez, L., Van Sande, J., Cochaux, P., Gervy, C., Mockel, J., Dumont, J., and Vassart, G. (1993). Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365, 649-651.
56. Pastan, I., and Johnson, G. S. (1974). Cyclic AMP and the transformation of fibroblasts. Adv. Cancer Res. 19, 303-329.
57. Pastan, I. H., Johnson, G. S., and Anderson, W. B. (1975). Role of cyclic nucleotides in growth control. Annu. Rev. Biochem. 44, 491-522.
58. Paternot, S., Arsenijevic, T., Coulonval, K., Bockstaele, L., Dumont, J. E., and Roger, P. P. (2006a). Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3, differential involvement in the distinct mitogenic modes of thyroid epithelial cells. Cell Cycle 5, 61-70.
59. Paternot, S., Coulonval, K., Dumont, J. E., and Roger, P. P. (2003). Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells. J. Biol. Chem. 278, 26533-26540.
60. Paternot, S., Dumont, J. E., and Roger, P. P. (2006b). Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations of human thyrocytes by growth factors and TSH. Mol. Endocrinol. 20, 3279-3292.
61. Rebhun, L. I. (1977). Cyclic nucleotides, calcium, and cell division. Int. Rev. Cytol. 49, 1-54.
62. Richards, J. S. (2001). New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol. Endocrinol. 15, 209-218.
63. Rivas, M., and Santisteban, P. (2003). TSH-activated signaling pathways in thyroid tumorigenesis. Mol. Cell Endocrinol. 213, 31-45.
64. Roger, P., Taton, M., Van Sande, J., and Dumont, J. E. (1988). Mitogenic effects of thyrotropin and adenosine 3′,5′-monophosphate in differentiated normal human thyroid cells in vitro. J. Clin. Endocrinol. Metab. 66, 1158-1165.
65. Roger, P. P., Baptist, M., and Dumont, J. E. (1992). A mechanism generating heterogeneity in thyroid epithelial cells: suppression of the thyrotropin/cAMP-dependent mitogenic pathway after cell division induced by cAMP-independent factors. J. Cell Biol. 117, 383-393.
66. Roger,P. P., Reuse, S., Maenhaut, C.,and Dumont,J. E. (1995). Multiple facets of the modulation of growth by cAMP. Vitam. Horm. 51, 59-191.
67. Roger, P. P., Servais, P., and Dumont, J. E. (1983). Stimulation by thyrotropin and cyclic AMP of the proliferation of quiescent canine thyroid cells cultured in a defined medium containing insulin. FEBS Lett. 157, 323-329.
68. Roux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P., and Blenis, J. (2004). Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. USA 101, 13489-13494.
69. Sabatini, D. M. (2006). mTOR and cancer: insights into a complex relationship. Nat. Rev. Cancer 6, 729-734.
70. Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., and Sabatini, D. M. (2007). PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25, 903-915.
71. Sarbassov, D. D., Guertin, D. A., Ali, S. M., and Sabatini, D. M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101.
72. Schwindinger, W. F., Francomano, C. A., and Levine, M. A. (1992). Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc. Natl. Acad. Sci. USA 89, 5152-5156.
73. Sewing,A.,Burger,C.,Brusselbach,S.,Schalk,C.,Lucibello,F. C.,and Muller, R. (1993). Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J. Cell Sci. 104, 545-555.
74. Sherr, C. J., and Roberts, J. M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
75. Soares, P., Trovisco, V., Rocha, A. S., Lima, J., Castro, P., Preto, A., Maximo, V., Botelho, T., Seruca, R., and Sobrinho-Simoes, M. (2003). BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22, 4578-4580.
76. Squires, M. S., Nixon, P. M., and Cook, S. J. (2002). Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1. Biochem. J. 366, 673-680.
77. Stork, P. J., and Schmitt, J. M. (2002). Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12, 258-266.
78. Tassan, J. P., Schultz, S. J., Bartek, J., and Nigg, E. A. (1994). Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J. Cell Biol. 127, 467-478.
79. Van Keymeulen, A., Bartek, J., Dumont, J. E., and Roger, P. P. (1999). Cyclin D3 accumulation and activity integrate and rank the comitogenic pathways of thyrotropin and insulin in thyrocytes in primary culture. Oncogene 18, 7351-7359.
80. Van Keymeulen, A., Deleu, S., Bartek, J., Dumont, J. E., and Roger, P. P. (2001). Respective roles of carbamylcholine and cyclic AMP in their synergistic regulation of cell cycle in thyroid primary cultures. Endocrinology 142, 1251-1259.
81. van Oirschot, B. A., Stahl, M., Lens, S. M., and Medema, R. H. (2001). Protein kinase A regulates expression of p27(kip1) and cyclin D3 to suppress proliferation of leukemic T cell lines. J Biol. Chem. 276, 33854-33860.
82. Vitagliano, D. et al. (2004). Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells. Cancer Res. 64, 3823-3829.
83. Wang, L., Harris, T. E., Roth, R. A., and Lawrence, J. C., Jr. (2007). PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol. Chem. 282, 20036-20044.
84. Ward, A. C., Csar, X. F., Hoffmann, B. W., and Hamilton, J. A. (1996). Cyclic AMP inhibits expression of D-type cyclins and cdk4 and induces p27Kip1 in G-CSF-treated NFS-60 cells. Biochem. Biophys. Res. Commun. 224, 10-16.
85. Weinstein, L. S., Shenker, A., Gejman, P. V., Merino, M. J., Friedman, E., and Spiegel, A. M. (1991). Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med. 325, 1688-1695.
86. Withers, D. J., Bloom, S. R., and Rozengurt, E. (1995). Dissociation of cAMP- stimulated mitogenesis from activation of the mitogen-activated protein ki- nase cascade in Swiss 3T3 cells. J Biol. Chem. 270, 21411-21419.
87. Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., and McMahon, M. (1997). Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17, 5598-5611.
88. Zarkowska, T., and Mittnacht, S. (1997). Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272, 12738-12746.
89. Zhang, H., Hannon, G. J., and Beach, D. (1994). p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8, 1750-1758.